BATS BZX Real-Time Price
As of 10:23am ET
| +0.50 / +3.28%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 23.50, with a high estimate of 31.00 and a low estimate of 15.00. The median estimate represents a +49.21% increase from the last price of 15.75.
The current consensus among 9 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.